Status:

COMPLETED

Diet and Medical Therapy Versus Bariatric Surgery in Type 2 Diabetes

Lead Sponsor:

Catholic University of the Sacred Heart

Conditions:

Type 2 Diabetes

Eligibility:

All Genders

30-60 years

Phase:

NA

Brief Summary

It is generally held that ß-cell function is irreversibly lost already at the time the disease manifests itself and thereafter continues to decline linearly with time. Several studies, however, have d...

Detailed Description

ß-cell dysfunction and insulin resistance are the main pathophysiological defects responsible for the development of hyperglycaemia \[1\]. Both these defects predict incident diabetes in high-risk sub...

Eligibility Criteria

Inclusion

  • patients with type 2 diabetes and BMI ≥35 kg.m-2
  • age between 30 and 60 years
  • duration of diabetes ≥ 5 years
  • poor glycemic control (i.e., HbA1c ≥ 7.0%) in spite a medical antidiabetic therapy in accordance with good clinical practice (GCP)

Exclusion

  • pregnancy
  • medical conditions requiring acute hospitalisation
  • severe diabetes complications or associated medical conditions (such as blindness, end-stage renal failure, liver cirrhosis, malignancy, chronic congestive heart failure)
  • recent (within preceding 12 months) myocardial infarction, stroke or TIA
  • unstable angina pectoris
  • psychological conditions which may hamper patient's cooperation
  • geographic inaccessibility
  • any condition which, in the judgement of the Investigator, may make risky the participation in the study or bias the results

Key Trial Info

Start Date :

April 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 1 2011

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT00888836

Start Date

April 1 2009

End Date

November 1 2011

Last Update

September 16 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Catholic University, Faculty of Medicine

Rome, Italy, 00168